Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bayer claims compounds with antitumor activity

Aug. 28, 2002

Kansas State University researchers identify nucleoside transport inhibitor TT-24

Aug. 28, 2002

ABI-007, a new cremophor-free nanoparticle formulation of paclitaxel

Aug. 28, 2002

Boehringer Ingelheim claims telomerase-inhibiting carboxamides

Aug. 27, 2002

SGN-15 enters phase II in advanced ovarian cancer

Aug. 27, 2002

Gleevec granted priority review for first-line use in early CML

Aug. 27, 2002

Oncogene BRAF is mutated in a high proportion of human melanomas

Aug. 27, 2002

Xcytrin to enter new phase III trial in NSCLC patients

Aug. 26, 2002

Novel HDAC inhibitors in early development at Roche

Aug. 23, 2002

STO-609, a potent and selective CaM-KK inhibitor synthesized at Sumitomo

Aug. 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...